drugset / Trial / NCT05198596
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the immunogenicity and safety of MVC- COV1901 vaccine compared to AZD1222 in heathy adults.
Timeline
- Start
- 2022-07-30
- Primary completion
- 2022-11-04
- Completion
- 2023-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AZD1222 | Vaccine | — | Intramuscular |
| Subject | MVC-COV1901 | Vaccine | — | Intramuscular |
Indications
No indication recorded.